Consegna in 90 minuti Gratis da 29,90€ e reso gratis sempre
-
-16%
Daflon 500mg 30 Coated Tablets
- Brand: SERVIER ITALIA SpA
- Product Code: 023356025
- EAN:
- Availability: In Stock (evaso in 24 ore)
- 3 items
for 14,67€ each - 4 items
for 14,37€ each - 5 items
for 14,07€ each
Daflon 500 in 30 coated tablets: what is it and what is it used for?
Daflon 500 is a vasoprotective drug based on micronized flavonoic fraction, useful in case of hemorrhoids and in the treatment of disorders attributable to venous insufficiency and capillary fragility.
Composition of Daflon 500:
Each film-coated tablet contains: Active ingredient purified flavonoic fraction, micronized 500 mg. Made up of: diosmin 450 mg; flavonoids expressed in hesperidin 50 mg. For the full list of excipients, see section 6.1.
Excipients
Sodium carboxymethyl starch, microcrystalline cellulose, gelatin, glycerin, hypromellose, sodium lauryl sulfate, yellow iron oxide E172, red iron oxide E 172, titanium dioxide, macrogol 6000, magnesium stearate, talc.
Therapeutic indications
Symptoms attributable to venous insufficiency; states of capillary fragility.
Contraindications
Hypersensitivity to the active substance or to any of the excipients.
Dosage
2 film-coated tablets per day (1 at noon and 1 in the evening) at mealtimes, even in venous insufficiency of the haemorrhoidal plexus.
Warnings and Precautions
None
Interactions
Do not report.
Side effects
The following adverse effects or reactions have been reported and ranked under the following frequency: very common (≥1 / 10); common (≥1 / 100 to <1/10); uncommon (≥1 / 1,000 to <1/100); rare (≥1 / 10,000, <1 / 1,000); very rare (<1 / 10,000), not known (cannot be estimated from the available data). Nervous system disorders Rare: dizziness, headache, malaise Gastrointestinal disorders Common: diarrhea, dyspepsia, nausea, vomiting Uncommon: colitis Skin and subcutaneous tissue disorders Rare: rash, pruritus, urticaria. Not known: isolated cases of edema of the face, lips, eyelid. Exceptionally Quincke's edema. Blood and lymphatic system disorders A few cases of thrombocytopenia, the frequency of which is unknown, have been reported in the post-marketing setting.
Pregnancy and breastfeeding
Pregnancy The safety of the drug in pregnancy has not been established, therefore it is advisable not to administer the product during pregnancy. Lactation In the absence of data on milk excretion, treatment should be avoided during lactation.
Format
30 tablets
